Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 33, 2018 - Issue 1
Submit an article Journal homepage
1,638
Views
26
CrossRef citations to date
0
Altmetric
Short Communication

1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders

Ondrej BenekUniversity of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic; ;University Hospital in Hradec Kralove, Biomedical Research Center, Hradec Kralove, Czech Republic; ;National Institute of Mental Health, Klecany, Czech Republic; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6840-1933View further author information
ORCID Icon,
Lukas HrochUniversity Hospital in Hradec Kralove, Biomedical Research Center, Hradec Kralove, Czech Republic; ORCID Iconhttp://orcid.org/0000-0001-9005-7630View further author information
ORCID Icon,
Laura AitkenUniversity of St. Andrews, Medical and Biological Sciences Building, School of Biology, St. Andrews, UK; ORCID Iconhttp://orcid.org/0000-0001-7259-4491View further author information
ORCID Icon,
Frank Gunn-MooreUniversity of St. Andrews, Medical and Biological Sciences Building, School of Biology, St. Andrews, UK; ORCID Iconhttp://orcid.org/0000-0003-3422-3387View further author information
ORCID Icon,
Lucie VinklarovaUniversity of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic; ;University Hospital in Hradec Kralove, Biomedical Research Center, Hradec Kralove, Czech Republic; ORCID Iconhttp://orcid.org/0000-0002-4779-5053View further author information
ORCID Icon,
Kamil KucaUniversity of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic; ;University Hospital in Hradec Kralove, Biomedical Research Center, Hradec Kralove, Czech Republic; ORCID Iconhttp://orcid.org/0000-0001-9664-1109View further author information
ORCID Icon,
Daniel I. PerezCentro de Investigaciones Biologicas-CSIC, Madrid, Spain; ORCID Iconhttp://orcid.org/0000-0003-1774-4471View further author information
ORCID Icon,
Concepcion PerezInstituto de Quimica Medica-CSIC, Madrid, Spain; ORCID Iconhttp://orcid.org/0000-0001-7183-4035View further author information
ORCID Icon,
Ana MartinezCentro de Investigaciones Biologicas-CSIC, Madrid, Spain; ORCID Iconhttp://orcid.org/0000-0002-2707-8110View further author information
ORCID Icon,
Zdenek FisarCharles University and General University Hospital in Prague, First Faculty of Medicine, Department of Psychiatry, Prague, Czech RepublicView further author information
&
Kamil MusilekUniversity of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic; ;University Hospital in Hradec Kralove, Biomedical Research Center, Hradec Kralove, Czech Republic; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7504-4062View further author information
ORCID Icon show all
Pages 665-670 | Received 10 Jan 2018, Accepted 21 Feb 2018, Published online: 14 Mar 2018

References

  • Perez DI, Gil C, Martinez A. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med Res Rev 2011;31:924–54.
  • Li G, Yin H, Kuret J. Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J Biol Chem 2004;279:15938–45.
  • Kannanayakal TJ, Tao H, Vandre DD, Kuret J. Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions. Acta Neuropathol 2006;111:413–21.
  • Flajolet M, He G, Heiman M, et al. Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I . Proc Natl Acad Sci USA 2007;104:4159–64.
  • Kametani F, Nonaka T, Suzuki T, et al. Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun 2009;382:405–9.
  • Salado IG, Redondo M, Bello ML, et al. Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J Med Chem 2014;57:2755–72.
  • Hroch L, Benek O, Guest P, et al. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment. Bioorg Med Chem Lett 2016;26:3675–8.
  • Burger A. Isosterism and bioisosterism in drug design. Prog Drug Res 1991;37:287–371.
  • Lim Y-A, Grimm A, Giese M, et al. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol. PLoS One 2011;6:e28887.
  • León R, Garcia AG, Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. Med Res Rev 2013;33:139–89.
  • ACD/Labs PhysChemSuite 14.0, Advanced Chemistry Development, Inc., Toronto, On, Canada. Available from: www.acdlabs.com, 2014.
  • Di L, Kerns EH, Fan K, et al. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223–32.
  • Cavalli A, Bolognesi ML, Minarini A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008;51:347–72.
  • Cardoso FL, Brites D, Brito MA. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev 2010;64:328–63.
  • van Asperen J, Mayer U, van Tellingen O, Beijnen JH. The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci 1997;86:881–4.
  • Wager TT, Hou X, Verhoest PR, Villalobos A. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem Neurosci 2010;1:435–49.
  • Crivori P, Cruciani G, Carrupt PA, Testa B. Predicting blood-brain barrier permeation from three-dimensional molecular structure. J Med Chem 2000;43:2204–16.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.